• Products
    • Biosensor Assays
      • TempoATP™ for ATP Metabolism
      • TempoCAL™ for Calcium
      • TempoMito™ for Mitochondria
      • TempoO2™ for Oxygen Metabolism
      • TempoVOL™ for Cationic Voltage
    • Induced Pluripotent Stem Cells (IPSC)
      • iAstro™ Astrocytes
      • iBMEC™ Brain Microvascular Endothelial Cells
      • iCardio™ Cardiomyocytes
      • iCort™ Cortical Neurons
      • iDopaNer™ Dopaminergic Neurons
      • iHep3D™ Hepatocytes
      • iHepStellate™ Hepatic Stellate
      • iHepStellate™-iKupffer™-iLSEC™-iHep3D™ 3D organoid
      • iKer™ Keratinocytes
      • iKidneyPod™ Kidney Proximal Tubules and Podocyte 3D Spheroids
      • iKupffer™ Kupffer Cells
      • iLSEC™ Liver Sinusoidal Endothelials
      • iMel™ Melanocytes
      • iMG™ Microglia
      • iMono™ CD14+ Monocytes
      • iMotorNer™ Motor Neurons
      • iMSC™ Mesenchymal
      • iNStem™ Neural Progenitor
      • iOligo™ Oligodendrocyte Progenitor
      • iOsteo™ Osteoblasts
      • iPeri™ Pericytes
      • iPhago™ Phagocytes
      • iRPE™ Retinal Pigment Epithelials
      • iSchwann™ Schwann
      • iSenso™ Sensory Neurons
    • TempoStemBank™
    • Cell Culture Solutions
      • Cell Medium Products
      • Assay Reagents
      • Conditioned Media
  • Services & Support
    • Services
      • Bespoke Assays
      • Assay Partnerships
    • Support
  • Tempo Bioscience
    • Careers
    • Company Overview
    • News
    • Contact
  • Resources
    • Cell Culture Technique
    • Citation Alert
    • Disease Models
    • Editorials
    • Research Trends
Alzheimer’s Disease – Hypotheses Old and New – Part Two

Alzheimer’s Disease – Hypotheses Old and New – Part Two

by Karen O'Hanlon Cohrt | Nov 27, 2017 | Industry News, Trends

In our last post, we walked through some of the canonical hypotheses surrounding Alzheimer’s Disease (AD), but what about all the other hypotheses that are knocking around? Since AD’s discovery over a century ago countless ideas have emerged, yet the exact cause of...
The Promises and Problems with ADCs

The Promises and Problems with ADCs

by Karen O'Hanlon Cohrt | Nov 21, 2023 | Industry News, Trends

Antibody drug conjugates (ADCs) are targeted cancer therapies that combine the specificity of monoclonal antibodies with the potency of cytotoxic drugs. In contrast to conventional chemotherapies, which do not discriminate between healthy and cancerous cells, ADCs are...
A Strong Foundation Makes For A Strong House: New Understandings in Embryonic Epithelial Development

A Strong Foundation Makes For A Strong House: New Understandings in Embryonic Epithelial Development

by Allison Kennedy | Feb 17, 2023 | Industry News

In an article published in  genengnews.com, the findings of a research study “Topological Morphogenesis of Neuroepithelial Organoids” discovered new information about cell-to-cell tissue connectivity that provides an organizational backbone for further organ...
Learning from the Experts: An Interview with Ellen Moran, PhD., Lab Manager

Learning from the Experts: An Interview with Ellen Moran, PhD., Lab Manager

by Olwen Reina | Apr 27, 2016 | Industry News

Scientists are the explorers of the great unknown. They thrive on the inherently mysterious nature of their work and utilize their knowledge and instincts to engage with, better understand and predict the world and universe around us. One of the most valuable tools...
Learning from the Experts: An Interview with Nick Oswald, PhD., Founder and Managing Director of BitesizeBio.com and Co-Founder and Editorial Director of Catalytic Content

Learning from the Experts: An Interview with Nick Oswald, PhD., Founder and Managing Director of BitesizeBio.com and Co-Founder and Editorial Director of Catalytic Content

by Olwen Reina | Jun 26, 2016 | Industry News

“You just stay the course, and do what it is that you do, and grow while you’re doing it. Eventually it will either come full circle, or at least you’ll go to bed at night happy.”  –  Jon Bon Jovi “Don’t get too comfortable with who...
Learning from the Experts: An Interview with Ruby Yanru Chen-Tsai, PhD, CSO, SVP and Co-founder of Applied StemCells Inc.

Learning from the Experts: An Interview with Ruby Yanru Chen-Tsai, PhD, CSO, SVP and Co-founder of Applied StemCells Inc.

by Olwen Reina | May 22, 2016 | Industry News

“A scientist in his laboratory is not a mere technician: he is also a child confronting natural phenomena that impress him as though they were fairy tales.” – Marie Curie “All my life through, the new sights of Nature made me rejoice like a...
« Older Entries

About Tempo BioScience

Fascinated by self-assembly of cells in spheroids or organoids? Excited to develop and characterize functionally relevant human iPSC disease models? Tempo Bioscience is a cash-positive product-focused trendsetter in the areas of human iPSCs and novel proprietary biosensors. We are growing and are looking for key hires to expand.  Join us and be a part of the team that will grow the company from the ground up and build a business that lasts.

Our Mission is to develop patient-relevant iPSC-based models for 10,000+ human diseases to advance science and medicine. 

Our Values are respect, communication, and teamwork.

Resources

How Do Transwell and TEER Assays Help Us Understand Biological Barrier Function?

How Do Transwell and TEER Assays Help Us Understand Biological Barrier Function?

How do Transwell assays help model biological barriers in the lab? What does TEER tell us about barrier integrity and tight-junction strength? How can these assays advance our understanding of...

read more
Why and How Do We Study Keratinocytes?

Why and How Do We Study Keratinocytes?

In a previous article we introduced keratinocytes and looked at their biological functions and subtypes. Here, we explore some of the main reasons researchers study keratinocytes and the...

read more
2D vs 3D Cell Culture: Choosing the Right Model for Disease Research

2D vs 3D Cell Culture: Choosing the Right Model for Disease Research

In our last article, we compared 2D organ-on-a-chip devices and 3D organoids with respect to their use in drug discovery, highlighting their importance in modeling diseases and evaluating...

read more
  • Products
    • Biosensor Assays
      • TempoATP™ for ATP Metabolism
      • TempoCAL™ for Calcium
      • TempoMito™ for Mitochondria
      • TempoO2™ for Oxygen Metabolism
      • TempoVOL™ for Cationic Voltage
    • Induced Pluripotent Stem Cells (IPSC)
      • iAstro™ Astrocytes
      • iBMEC™ Brain Microvascular Endothelial Cells
      • iCardio™ Cardiomyocytes
      • iCort™ Cortical Neurons
      • iDopaNer™ Dopaminergic Neurons
      • iHep3D™ Hepatocytes
      • iHepStellate™ Hepatic Stellate
      • iHepStellate™-iKupffer™-iLSEC™-iHep3D™ 3D organoid
      • iKer™ Keratinocytes
      • iKidneyPod™ Kidney Proximal Tubules and Podocyte 3D Spheroids
      • iKupffer™ Kupffer Cells
      • iLSEC™ Liver Sinusoidal Endothelials
      • iMel™ Melanocytes
      • iMG™ Microglia
      • iMono™ CD14+ Monocytes
      • iMotorNer™ Motor Neurons
      • iMSC™ Mesenchymal
      • iNStem™ Neural Progenitor
      • iOligo™ Oligodendrocyte Progenitor
      • iOsteo™ Osteoblasts
      • iPeri™ Pericytes
      • iPhago™ Phagocytes
      • iRPE™ Retinal Pigment Epithelials
      • iSchwann™ Schwann
      • iSenso™ Sensory Neurons
    • TempoStemBank™
    • Cell Culture Solutions
      • Cell Medium Products
      • Assay Reagents
      • Conditioned Media
  • Services & Support
    • Services
      • Bespoke Assays
      • Assay Partnerships
    • Support
  • Tempo Bioscience
    • Careers
    • Company Overview
    • News
    • Contact
  • Resources
    • Cell Culture Technique
    • Citation Alert
    • Disease Models
    • Editorials
    • Research Trends
  • Follow

©2023 – 2025 TempoBioscience. All rights reserved. Privacy Policy | Terms of Use.

X